http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110038138-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1866 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
| filingDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110038138-B |
| titleOfInvention | Prussian blue nano-particles targeting Abeta age spots and preparation method thereof |
| abstract | The invention relates to a nano material in the field of biomedicine, in particular to a preparation method of Prussian blue nano particles targeting Abeta age spots. The Prussian blue nanoparticles are functionally modified, so that transferrin with a blood brain barrier penetrating function and Congo red molecules targeting the A beta senile plaques can be loaded, the prepared nanoparticles have good r1 longitudinal relaxation rate and r2 transverse relaxation rate, and MRI (T1/T2) simultaneous imaging of the A beta senile plaques can be realized. |
| priorityDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.